NKGen Biotech Announces Poster Presentation at the 16th Annu

SANTA ANA, Calif., Oct. 19, 2023 -- NKGen Biotech Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK...

Related Keywords

United States , California , Boston , Massachusetts , Thank Lee , Blanca Isaura Acosta Gallo , Kevin Gardner , Clemente Humberto Zuniga Gil , Sean Hong , Denise Chua , Rufino Menchaca Diaz , Chris Calabrese , Pauly Chang , Katia Betito , Lucia Hui , Cesar Alejandro Amescua , Juan Mata , Exchange Commission , Nkgen Biotech Inc , Corporate Communications , Nasdaq , Lifesci Advisors , Globenewswire Inc , Clinical Trials , Disease Annual Meeting , With Enhanced Activity , Final Report , Phasei Dose Escalation , Humberto Zuniga Gil , Isaura Acosta Gallo , Menchaca Diaz , Alejandro Amescua , Session Time , Looking Statements , Private Securities Litigation Reform Act , Investor Relations , Sci Advisors , Markets ,